Related Experiment Video
Updated: Jul 26, 2025

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods
Published on: March 10, 2020
Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease
1Section of Pediatric Cardiology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, 77030, USA. justin.zachariah@bcm.edu.
Insights
Youth with congenital heart disease (CHD) face higher risks of atherosclerotic cardiovascular disease (ASCVD). Early management of obesity, dyslipidemia, and hypertension is crucial for improving long-term health outcomes in these vulnerable patients.
Area of Science:
- Cardiology
- Pediatrics
- Preventive Medicine
Background:
- Youth with congenital heart disease (CHD) are at increased risk for atherosclerotic cardiovascular disease (ASCVD) due to genetic and acquired risk factors.
- Successful management of CHD necessitates addressing ASCVD risk factors to enhance patient longevity and outcomes.
Purpose of the Study:
- To review guidelines for evaluating and managing obesity, dyslipidemia, and hypertension in youth under 18.
- To highlight the specific vulnerabilities of CHD patients, particularly those with a history of cardiac surgery and residual disease.
Main Methods:
- Review of current clinical guidelines for ASCVD risk factor management in pediatric CHD patients.
- Focus on lifestyle, pharmacologic, and surgical interventions tailored to CHD survivors.
Main Results:
- Obesity, dyslipidemia, and hypertension are highly prevalent ASCVD risk factors in youth with CHD.
- Targeting these risk factors is essential to prevent ASCVD morbidity and mortality in CHD survivors.
- Regular assessment of global risk factors, lifestyle counseling, and timely pharmacotherapy/surgery are recommended.
Conclusions:
- Clinicians must proactively manage ASCVD risk factors in CHD patients to improve long-term health.
- Future research should focus on interventions to optimize risk factor identification and treatment in this population.
- Integrating comprehensive risk factor assessment and intervention into routine care is vital for CHD survivors.
Purpose Of Review:
Youth with congenital heart disease (CHD) are uniquely vulnerable to genetic and acquired atherosclerotic cardiovascular disease (ASCVD) risk factors. With the increasingly successful management of CHD, it is important to prevent or optimally managed risk factors with the goal of improving outcomes and longevity.
Recent Findings:
This review summarizes guidelines for the evaluation and management of obesity, dyslipidemia, and hypertension in youth (< 18 years of age), focusing on the special vulnerabilities associated with the type of repair and the presence of residual disease in those who undergo cardiac surgery. Clinicians must focus on targeting these highly prevalent ASCVD risk factors to protect CHD survivors from preventable ASCVD morbidity and mortality by applying lifestyle, pharmacologic, or surgical therapies as needed. Future work should examine interventions to identify and treat ASCVD risk factors in CHD patients. Given the increased prevalence of ASCVD risk factors in youth and the morbidity and premature mortality associated with CHD, it is important for clinicians to assess global risk factors in these patients frequently, encourage adherence to lifestyle changes, and recommend pharmacotherapy and surgical interventions when clinically indicated. Future efforts should identify barriers and opportunities for improving risk factor assessment and timely intervention as a routine part of clinical care.
Related Concept Videos
Coronary Artery Disease I: Introduction
Atherosclerosis I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Heart Failure I: Introduction
Rheumatic Heart Disease I: Introduction
Mitral Stenosis I: Introduction

